Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

304.94
Delayed Data
As of May 17
 -3.10 / -1.01%
Today’s Change
291.10
Today|||52-Week Range
442.00
-18.36%
Year-to-Date

Today’s Trading

Previous close308.04
Today’s open305.80
Day’s range303.70 - 309.21
Volume756,025
Average volume (3 months)781,219
Market cap$32.9B
Data as of 4:00pm ET, 05/17/2019

Growth & Valuation

Earnings growth (last year)+100.98%
Earnings growth (this year)-5.78%
Earnings growth (next 5 years)+11.17%
Revenue growth (last year)+14.28%
P/E ratio14.4
Price/Sales6.39
Price/Book3.80

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-0.50-0.38%
BAXBaxter International...-0.92-1.20%
VRTXVertex Pharmaceutica...-1.50-0.88%
AGNAllergan+0.16+0.11%
Data as of 4:02pm ET, 05/17/2019

Financials

Next reporting dateAugust 5, 2019
EPS forecast (this quarter)$5.31
Annual revenue (last year)$6.7B
Annual profit (last year)$2.4B
Net profit margin36.42%

Profile

Sector
Health Technology
Industry
Biotechnology
Co-President, Chief Executive Officer &
Director
Leonard S. Schleifer
Co-President, Director &
Chief Scientific Officer
George Damis Yancopoulos
Corporate headquarters
Tarrytown, New York

Forecasts